Progress in Breast Cancer Care: Translating SABCS Data Into Practice
Charles E. Geyer Jr., MD, FACP
Komal Jhaveri, MD, FACP
Addressing Unmet Needs in Metastatic Uveal Melanoma
Marlana Orloff, MD
Gregory Daniels, MD, PhD
Jesse Keller, MD
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
A.J. Gelderblom, MD, PhD
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
Michiel van de Sande, MD, PhD
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
Routes Reconsidered: A Case-Based Debate in SERD Selection
Giuseppe Curigliano, MD, PhD
Spotlight on Asia-Pacific: Practice Beyond Borders
Hiraji Iwata, MD, PhD
Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
Beyond Fulvestrant: Oral SERDs Redefining ER Targeting
Safety of CDK4/6 Inhibitors: Anticipation, Prevention, and Management of Adverse Events
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
Kathleen Moore, MD, MS
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
Joyce F. Liu, MD, MPH
MOA: CDH6-Targeted Antibody-Drug Conjugates
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.